Strategic Clarity: The New Currency in Life Science
In an industry shaped by rapid regulatory changes and global competition, leading life science companies are rethinking what it takes to succeed. Increasingly, expert support is no longer a luxury—it’s a strategic necessity.
“There has been a cultural shift in the industry,” says Ulrika Hammarström, Head of CRO Operations at Aurevia. “Expert support is now seen as something a company must have in order to succeed.”
“Strategic clarity is the new currency in life science,” adds Anna-Karin Alm, Head of QARA Operations at Aurevia. “Thoughtfulness, experience, and planning are more important than ever.”
Aurevia, a consultancy formed by merging several European firms, including QAdvis and Scandinavian CRO in Sweden, provides comprehensive support across the entire product lifecycle. From early development to market access and beyond, Aurevia’s multidisciplinary team brings deep expertise in quality assurance, regulatory affairs, and clinical research to empower pharma, biotech, and medtech innovators to navigate complexity and achieve lasting success.
Read the full article at Göteborg Life Science in Swedish or English to explore the key factors that characterize successful life science companies.
BREAKING